Veradigm Inc
OTC:MDRX

Watchlist Manager
Veradigm Inc Logo
Veradigm Inc
OTC:MDRX
Watchlist
Price: 4.85 USD
Market Cap: 528.2m USD

Veradigm Inc
Investor Relations

Veradigm Inc., formerly known as Allscripts Healthcare Solutions, has carved out a distinct niche within the healthcare technology landscape. The company focuses on the dynamic intersection of technology and healthcare, developing an array of solutions aimed at enhancing healthcare delivery and efficiency. Essentially, Veradigm equips medical professionals with tools for electronic health records, practice management, and remote patient monitoring. By leveraging sophisticated information systems, Veradigm helps streamline operations in doctor's offices, hospitals, and healthcare organizations, making it easier for healthcare providers to deliver efficient and effective services. Their products are designed not only to improve clinical workflows but also to enhance patient engagement, ultimately leading to better health outcomes.

The revenue model of Veradigm hinges largely on contractual agreements and subscriptions for its software solutions. By offering a range of cloud-based services, the company ensures a steady flow of recurrent income while reducing the need for expensive on-site installations, thus delivering value to both large hospital systems and smaller, private practices. Additionally, Veradigm has diversified its revenue streams through collaborations with pharmaceutical companies, providing data insights and support for research and marketing initiatives. With a persistent focus on innovation and adaptability, Veradigm not only strengthens its foundational business in healthcare IT but also taps into new opportunities within the emerging landscape of digital health and data analytics.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2022
Call Date
Nov 3, 2022
AI Summary
Q3 2022

Revenue Growth: Allscripts delivered consolidated revenue growth of 5% year-over-year, with the Veradigm segment up 6% and the payer and life sciences business up 10%.

Margin Expansion: Gross margin improved by over 1,200 basis points year-over-year, and Veradigm's gross margin reached 55.6%, up 630 basis points. Adjusted EBITDA margin rose to 30.1%, a 500 basis point improvement.

Strong Cash Flow: The company generated $34 million in free cash flow during the quarter and over $90 million year-to-date.

Share Repurchases: Management emphasized plans to significantly increase share buybacks in Q4 due to the perceived undervaluation of the stock.

Guidance Reaffirmed: Full-year guidance for revenue, adjusted EBITDA, and free cash flow was maintained; Veradigm revenue is expected to grow 6–7%, adjusted EBITDA 10–15%, and free cash flow to reach $110–$120 million.

Business Momentum: New wins in the payer, provider, and life sciences segments—including major contracts with Blue Cross plans and a biopharma company—drove growth and market expansion.

Margin Sustainability: Management indicated current margin levels are sustainable going forward.

Key Financials
Veradigm Gross Margin
55.6%
Adjusted EBITDA Margin
30.1%
Free Cash Flow
$34 million (Q3); over $90 million year-to-date
EPS
$0.12
Net Cash
$286 million
Share Repurchases
$34 million (Q3)
Average Fully Diluted Share Count
113.3 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. P. Gregory Garrison
Executive Chairman of the Board
No Bio Available
Ms. Tejal Vakharia J.D.
Senior VP of Marketing & Government Affairs, General Counsel and Chief Compliance Counsel
No Bio Available
Mr. Thomas J. Langan
Interim CEO
No Bio Available
Mr. Leland A. Westerfield
Interim CFO and Principal Financial & Accounting Officer
No Bio Available
Ms. Jenny Gelinas
Vice President of Investor Relations
No Bio Available
Mr. Richard Elmore
Senior Vice President of Corporate Development & Strategy
No Bio Available
Ms. Lisa Hammond C.P.C.
Senior VP & Chief Human Resources Officer
No Bio Available
Mr. John Sage
Senior Vice President of U.S. Hospitals & Health Systems Sales
No Bio Available
Mr. Elliot Bryant
Senior VP & General Manager for Classic Client Solutions Business Unit
No Bio Available
Mr. John Mayr
Senior Vice President of Global Client Delivery Organization
No Bio Available

Contacts

Address
ILLINOIS
Chicago
222 Merchandise Mart Plaza, Suite 2024
Contacts